Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 26;38(1):25.
doi: 10.1007/s00384-023-04319-7.

A proposal for grading the risk of lymph node metastasis after endoscopic resection of T1 colorectal cancer

Zhenghua Piao  1 , Rong Ge  2 , Chunnian Wang  2
Affiliations

A proposal for grading the risk of lymph node metastasis after endoscopic resection of T1 colorectal cancer

Zhenghua Piao et al. Int J Colorectal Dis. .

Abstract

Purpose: At present, for patients with early colorectal cancer as long as having any one risk factor of lymph node metastasis (LNM) after endoscopic resection (ER), additional surgery will be considered, regardless of the degree of LNM risk; however, most patients are free of LNM. This study aimed to further grade these patients according to LNM risk.

Methods: We assessed 271 patients with T1 colorectal cancers treated initially with ER to analyze the correlation between LNM-associated risk factors and LNM rate. Differences in this rate between groups were estimated using the χ2 test or Fisher's exact test.

Results: Poorly differentiated adenocarcinoma (Por) (3.4% vs. 40%, p < 0.001) and lymphovascular infiltration (LV) (1.6% vs. 29.0%, p < 0.001) were the only parameters correlated with LNM. When we divided the cases into LV-negative (LV(-)) and LV-positive (LV(+)) groups, we found a significantly higher LNM rate in the LV(+) group (29.0% vs. 1.6%, p < 0.001). Additionally, the rate of LNM in those positive for each parameter did not differ from the control rate in the same group, except in the Por subgroup. When the cases were divided into four groups based on the presence of LV infiltration and Por, the LNM rate in each group was 2/233 cases (0.8%) in the LV(-)Por(-) group, 2/7 cases (28.5%) in the LV(-)Por(+) group, 7/28 cases (25.0%) in the LV(+)Por(-) group, and 2/3 cases (66.6%) in the LV(+)Por(+) group.

Conclusions: Based on LV and histological differentiation, patients were classified into three LNM risk grades: low (LNM, 0.8%), moderate (LNM, 25.0-28.5%), and high (LNM, 66.6%).

Keywords: Endoscopic resection; Lymph node metastasis; Pathologic diagnosis; Risk factor; T1 colorectal cancer.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. For the Study Group for Budding/Sprouting in Colorectal Cancer of the Japanese Society for Cancer of the Colon and Rectum (JSCCR), Kawachi H, Eishi Y et al (2015) A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer: a retrospective multicenter study. Mod Pathol 28:872–879. https://doi.org/10.1038/modpathol.2015.36
    1. Nakadoi K, Tanaka S, Kanao H et al (2012) Management of T1 colorectal carcinoma with special reference to criteria for curative endoscopic resection: management of T1 colorectal carcinoma. J Gastroenterol Hepatol 27:1057–1062. https://doi.org/10.1111/j.1440-1746.2011.07041.x - DOI - PubMed
    1. Suh JP, Youk EG, Lee EJ et al (2013) Endoscopic submucosal dissection for nonpedunculated submucosal invasive colorectal cancer: is it feasible? Eur J Gastroenterol Hepatol 25:1051–1059. https://doi.org/10.1097/MEG.0b013e328361dd39 - DOI - PubMed
    1. Tateishi Y, Nakanishi Y, Taniguchi H et al (2010) Pathological prognostic factors predicting lymph node metastasis in submucosal invasive (T1) colorectal carcinoma. Mod Pathol 23:1068–1072. https://doi.org/10.1038/modpathol.2010.88 - DOI - PubMed
    1. Oh JR, Park B, Lee S et al (2019) Nomogram development and external validation for predicting the risk of lymph node metastasis in T1 colorectal cancer. Cancer Res Treat 51:1275–1284. https://doi.org/10.4143/crt.2018.569 - DOI - PubMed - PMC

LinkOut - more resources